GlassScriptPhysician profile
Alexander Tuchman
NPI 1730473232
$2,575.18
in general payments reported to CMS, 2019-2025
7 companies · $479 in 2025
The $479 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $309 · 2022: $430 · 2023: $954 · 2024: $403 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,836.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,103.84 | 2021-2025 | Mazor X System, Unid_pass, Plasmablade(Tm) |
| Globus Medical, INC. | $718.45 | 2021-2025 | Reline, Excelsiusgps Robotic Navigation System, Excelsius Gps |
| Nuvasive, INC. | $338.85 | 2023 | Xlif, Reline, Tlif |
| Smaio Sa | $152.38 | 2023 | |
| Nevro Corp. | $124.50 | 2022 | |
| Abbott Laboratories | $88.13 | 2022 | |
| Biocomposites INC | $49.03 | 2023 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Tuchman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.